Form 8-K - Current report:
SEC Accession No. 0001144204-13-013432
Filing Date
2013-03-07
Accepted
2013-03-07 09:21:29
Documents
2
Period of Report
2013-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v337426_8-k.htm 8-K 14951
2 EXHIBIT-99.1 v337426_ex99-1.htm EX-99.1 12815
  Complete submission text file 0001144204-13-013432.txt   29094
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 13671692
SIC: 2836 Biological Products, (No Diagnostic Substances)